China is set to ease restrictions on some Illumina products, giving the sequencing giant a partial reprieve. Since March, Illumina has been barred from exporting its DNA sequencers to China,…
Illumina’s revenue was flat for the third quarter as the sequencing giant continues to deal with headwinds from a China sales ban. The $1.08 billion it brought in for the…
Illumina is launching a new informatics and artificial intelligence software business aimed at drug developers, with the goal of digesting large-scale DNA sequencing and multi-omics data. The BioInsight division plans…
Illumina has begun rolling out its protein research platform, powered in part by tech from SomaLogic, which the DNA sequencing giant signed up to buy out a few months ago…